Article
PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery.
European respiratory review : an official journal of the European Respiratory Society - 1 Jun 2013
Maher Toby M
Abstract excerpt
Despite major advances in the understanding of the pathogenesis of idiopathic pulmonary fibrosis (IPF), diagnosis and management of the condition continue to pose significant challenges. Clinical management of IPF remains unsatisfactory due to limited availability of effective drug therapies, a lack of accurate indicators of disease progression, and an absence of simple short-term measures of therapeutic...
Topics
Join the communities discussing this publication.